A meta-analysis of topical prostaglandin analogs in the treatment of chronic angle-closure glaucoma

Journal of Glaucoma

Volumn 18, Issue 9, 2009, Pages 652-657

  Cheng, Jin Wei ^a   Cai, Ji Ping ^a   Li, You ^a   Wei, Rui Li ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chronic angle closure glaucoma; Prostaglandin analogs; Timolol

Indexed keywords

BIMATOPROST; LATANOPROST; PROSTAGLANDIN DERIVATIVE; TIMOLOL; TRAVOPROST;

ARTICLE; CHINESE MEDICINE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; COCHRANE LIBRARY; DRUG EFFICACY; EMBASE; HUMAN; INTRAOCULAR PRESSURE; LONG TERM CARE; MEDLINE; META ANALYSIS; MONOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ADMINISTRATION, TOPICAL; AGED; CHRONIC DISEASE; DATABASES, FACTUAL; FEMALE; GLAUCOMA, ANGLE-CLOSURE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PROSTAGLANDINS, SYNTHETIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 74549115742     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e31819c49d4     Document Type: Article

References (31)

1. Thylefors B, Négrel AD, Pararajasegaram R, et al. Global data on blindness. Bull World Health Organ. 1995;73:115-121
2. Foster PJ, Baasanhu J, Alsbirk PH, et al. Glaucoma in Mongolia. A population-based survey in Hövsgöl province, northern Mongolia. Arch Ophthalmol. 1996;114:1235-1241
3. Foster PJ, Oen FT, Machin D, et al. The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district. Arch Ophthalmol. 2000;118:1105-1111
4. Bourne RR, Sukudom P, Foster PJ, et al. Prevalence of glaucoma in Thailand: a population based survey in Rom Klao District, Bangkok. Br J Ophthalmol. 2003;87:1069-1074
5. Yamamoto T, Iwase A, Araie M, et al, Tajimi Study Group, Japan Glaucoma Society. The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology. 2005;112:1661-1669
6. He M, Foster PJ, Ge J, et al. Prevalence and clinical characteristics of glaucoma in adult Chinese: a populationbased study in Liwan District, Guangzhou. Invest Ophthalmol Vis Sci. 2006;47:2782-2788
7. Vijaya L, George R, Arvind H, et al. Prevalence of angleclosure disease in a rural southern Indian population. Arch Ophthalmol. 2006;124:403-409
8. Robin AL, Pollack IP. Argon laser peripheral iridotomies in the treatment of primary angle closure glaucoma. Long-term follow-up. Arch Ophthalmol. 1982;100:919-923
9. McGalliard JN, Wishart PK. The effect of Nd: YAG iridotomy on intraocular pressure in hypertensive eyes with shallow anterior chambers. Eye. 1990;4:823-829
10. Alsagoff Z, Aung T, Ang LP, et al. Long-term clinical course of primary angle-closure glaucoma in an Asian population. Ophthalmology. 2000;107:2300-2304
11. Rosman M, Aung T, Ang LP, et al. Chronic angle-closure with glaucomatous damage: long-term clinical course in a North American population and comparison with an Asian population. Ophthalmology. 2002;109:2227-2231
12. Hurvitz LM, Kaufman PL, Robin AL, et al. New developments in the drug treatment of glaucoma. Drugs. 1991;41: 514-532
13. Alm A. Prostaglandin derivates as ocular hypotensive agents. Prog Retin Eye Res. 1998;17:291-312
14. Li N, Chen XM, Zhou Y, et al. Travoprost compared with other prostaglandin analogues or timolol in patients with openangle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials. Clin Exp Ophthalmol. 2006;34: 755-764
15. Zhang WY, Po AL, Dua HS, et al. Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension. Br J Ophthalmol. 2001;85:983-990
16. Sacks HS, Berrier J, Reitman D, et al. Meta-analyses of randomized controlled trials. N Engl JMed. 1987;316:450-455
17. Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ. 1997;315:1533-1537
18. Pogue J, Yusuf S. Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet. 1998; 351:47-52
19. van der Valk R, Webers CA, Schouten JS, et al. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. Ophthalmology. 2005;112:1177-1185
20. Verhagen AP, de Vet HC, de Bie RA, et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol. 1998;51:1235-1241
21. Aung T, Wong HT, Yip CC, et al. Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study. Ophthalmology. 2000;107:1178-1183
22. Chew PT, Aung T, Aquino MV, et al, EXACT Study Group. Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma. Ophthalmology. 2004;111:427-434 (Pubitemid 38293094)
23. Sihota R, Saxena R, Agarwal HC, et al. Crossover comparison of timolol and latanoprost in chronic primary angle-closure glaucoma. Arch Ophthalmol. 2004;122:185-189
24. Kong XM, Sun XH, Ge L, et al. The clinical study of latanoprost in treating with residual angle-closure glaucoma. Zhongguo Shiyong Yanke Zazhi. 2005;23:475-478
25. Sakai H, Shinjyo S, Nakamura Y, et al. Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients. J Ocul Pharmacol Ther. 2005;21:483-489
26. Chen MJ, Chen YC, Chou CK, et al. Comparison of the effects of latanoprost and travoprost on intraocular pressure in chronic angle-closure glaucoma. J Ocul Pharmacol Ther. 2006; 22:449-454
27. Chew PTK, Pongpun PR, Euswas A, et al. Intraocular pressure-lovering effect and safety of travoprost 0.004% and latanoprost 0.005% for the treatment of chronic angle closure glaucoma. Asian J Ophthalmol. 2006;8:13-19
28. Chen MJ, Chen YC, Chou CK, et al. Comparison of the effects of latanoprost and bimatoprost on intraocular pressure in chronic angle-closure glaucoma. J Ocul Pharmacol Ther. 2007; 23:559-566
29. RojanaPongpun P, Pandav S, Reyes MR, et al. Comparison of the efficacy and safety of bimatoprost and timolol for treatment of chronic angle closure glaucoma. Asian J Ophthalmol. 2007;9:239-244
30. DerSimonian R, Kacker R. Random-effects model for metaanalysis of clinical trials: an update. Contemp Clin Trials. 2007; 28:105-114
31. Egger M, Davey Smith G, Schneider M, et al. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997;315: 629-634